X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
1
Enter email and you're done. No subscription, no credit card.
2
Search, tap and you're done. Over 3,400 medicines.
3
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
An appointment for a CT or MRI scan often comes at short notice — and with it the question of what to do about your tablets. The most important answer first: almost all long-term medicines are simply continued. Only a few genuinely need a decision, and that decision is made by your GP practice or the radiology department. The single most important case is metformin — and that is precisely where the rule many people still carry around in their heads no longer holds in such a blanket form.
Your current medication plan on your phone — instead of a scrap of paper in your wallet.
"Contrast agent" is an umbrella term for very different substances. For the question of your medicines, two groups matter — and they have different weak points.
| Group | Where it is used | Critical organ | Typical question beforehand |
|---|---|---|---|
| Iodine-containing contrast agents | CT, angiography, X-ray with contrast, cardiac catheterisation | Kidneys and thyroid | Kidney values, metformin, an overactive thyroid |
| Gadolinium-containing contrast agents | MRI / magnetic resonance imaging | Kidneys | Kidney values where function is severely reduced |
The crucial difference: only iodine-containing contrast agents are an issue for the thyroid — gadolinium contains no iodine. What both groups have in common is that they are excreted through the kidneys. That is why kidney function is central to both examinations, only with different consequences.
Contrast agents leave the body through the kidneys. If the kidneys are working well, that is done within a few hours. If function is reduced, the substance stays in the body longer — and in rare cases kidney function can drop further for a while after it is given. The technical term for this is contrast-associated kidney injury.¹
The value in question is the eGFR (estimated glomerular filtration rate) — an estimate, calculated from creatinine, of how much blood the kidneys filter per minute. What the number means is explained in the guide Understanding blood values.
How recent the values need to be depends on your history: with stable kidney function a result from the past few weeks or months is often enough, while with known chronic kidney disease or a recent deterioration a new measurement is taken.
This is where most of the questions arise — and where most has changed. Metformin is the most commonly prescribed medicine for type 2 diabetes, so it is on the list of a great many people going for a CT scan.
Metformin itself does not damage the kidneys — the problem runs the other way round: the substance is excreted through the kidneys. If kidney function drops markedly, it accumulates, and the risk of lactic acidosis (over-acidification of the blood by lactic acid) rises — a very rare but serious complication. So the concern is not that metformin and contrast agent react with each other, but this: if the contrast agent makes kidney function worse, metformin would suddenly be dosed too high.²
For decades the instruction was: stop metformin on the day of the examination and do not take it for 48 hours afterwards. The advantage was that it was easy to remember. The drawback: it treated everyone the same — including the large majority with normal kidney function, in whom a relevant drop after intravenous contrast is very unlikely. The price was two days without basic diabetes treatment, and the real risk that the tablet is then simply forgotten.
The current recommendations of the professional bodies — in Europe the ESUR contrast agent guideline, supported in Germany by the German Radiological Society (Deutsche Röntgengesellschaft) — therefore take a kidney-value-dependent approach: with normal or only mildly reduced kidney function and intravenous administration, metformin can as a rule be continued without interruption. Only with markedly reduced function, acute deterioration or certain arterial administrations is it paused, with restarting tied to a follow-up check.¹
What else is worth bearing in mind around a metformin break in everyday life — from sick days to fasting — is covered in the guide Diabetes medications in everyday life. Background on the condition itself can be found under Diabetes.
If there was a break, the second half of the rule applies — and it is forgotten more often than the first. Restarting is tied to a condition, not just to a waiting time. The usual approach: no earlier than about 48 hours, and only after the kidney values have been checked again and shown to be stable.²
In practice that means: if you go for a CT scan on Monday and are told to pause, you need an appointment for a blood test by Wednesday at the latest — otherwise the break drags on unplanned. If you have not arranged a check, it is better to phone than simply to start again or to keep pausing for weeks.
A simple note helps in practice: date of the examination, date of the check, date of restarting — see Keeping a medication list.
brite reminds you of the day your medicine starts again.
Metformin gets the attention — yet it is two other groups that can genuinely put a strain on kidney function around the appointment.
Anti-inflammatory painkillers such as Ibuprofen and Diclofenac reduce blood flow to the kidneys. With healthy kidneys and short-term use that has no consequences. But when several factors come together — reduced kidney function, not having drunk much, plus contrast agent — the strain adds up. Many of these medicines are available over the counter and therefore appear on no medication plan.
Whether you pause them around the appointment is a medical decision. With painkillers taken as needed it is often possible to switch to a different substance for a few days — see Painkillers compared.
Loop diuretics such as Furosemide and Torasemide draw fluid out of the body — exactly the state in which the kidneys cope worst with contrast agent. At the same time they are indispensable in heart failure: leaving them out on your own initiative can trigger a deterioration and is not an option. So raise it, do not decide it yourself.
Iodine-containing contrast agents contain many times the amount of iodine the body needs in a day. With a healthy thyroid this sorts itself out. With an overactive thyroid or thyroid autonomy — areas that produce hormones independently of the body's control — the surge of iodine can drive hormone production up sharply. This can occur days to weeks later and show itself as a racing heart, inner restlessness, trembling, weight loss and sleep problems.³
That is why the TSH level is often measured before a CT scan with contrast. A thyroid condition belongs in the consent conversation without being asked about — even if it has been stable for years. With MRI using gadolinium the question does not arise.
Something has been getting confused here for decades — and the confusion leads people to put off examinations that would be entirely unproblematic for them.
What does count is a previous reaction to a contrast agent itself. That is exactly what the consent form asks about — with as much detail as possible: which year, which examination, which symptoms, treated how?
Anyone who has reacted before can usually still be examined: often a different preparation is used, and sometimes pre-treatment is considered. What matters is that the information gets through and is documented — see Medication side effects.
Good fluid intake is the simplest measure you can contribute yourself. It helps the kidneys to excrete the contrast agent promptly.
Where kidney function is markedly reduced, hospitals often use an infusion of saline solution before and afterwards — that is where the evidence is strongest. For simply "drinking plenty" with otherwise healthy kidneys the evidence is weaker: plausible, harmless, widely recommended — but solid proof of benefit is missing. Saying so honestly changes nothing about the recommendation; it only counters the idea that a litre of water could offset a real risk.¹
With MRI the list of questions beforehand is shorter: gadolinium does not affect the thyroid, and the metformin question does not arise in the same way. That leaves the kidneys.
Historically, nephrogenic systemic fibrosis was the reason for all the caution — a very rare but serious condition involving hardening of the skin and internal organs, which occurred with older gadolinium preparations in people with severely reduced kidney function. The European regulators responded: the linear preparations classified as riskier have largely been withdrawn from the market, and today mostly more stable macrocyclic substances are used. New cases have become very rare as a result.⁴
A second point matters more with MRI than with CT: metal in or on the body. As well as pacemakers, implants and pumps, this includes medicated patches with a metal-containing backing foil — some can heat up in the magnetic field and are removed beforehand.
The interaction check shows you critical combinations in seconds.
Most delays in radiology are caused not by medical problems but by missing information:
How to prepare for a conversation like this so that nothing gets lost is covered in the guide Preparing for a doctor's appointment. If a procedure is coming up as well, it is worth looking at Medications before surgery — some of the rules there are different, particularly for blood thinners.
| Medicine / group | Relevant with | What it is about | Usual approach |
|---|---|---|---|
| Metformin | Iodine-containing (CT) | Accumulation if kidney function drops | Depends on the kidney values — often continued; paused with a follow-up check where function is reduced |
| Insulin, sulfonylureas | Both | Hypoglycaemia at a fasting appointment | Clarify with the practice beforehand, take glucose tablets with you |
| NSAIDs (ibuprofen, diclofenac) | Both | Additional strain on the kidneys | Where there is a risk, pause as agreed with your doctor; otherwise continue |
| Furosemide, torasemide | Both | Fluid depletion increases the risk | Never leave out on your own initiative; raise it and watch your fluid intake |
| Antithyroid drugs for an overactive thyroid | Iodine-containing (CT) | A surge of iodine can worsen an overactive thyroid | Continue as prescribed, clarify thyroid status beforehand |
| Levothyroxine | — | No known problem with contrast agents | Carry on as usual |
| Blood pressure medicines and blood thinners | Both | Evidence thin, or only relevant where there is a procedure | Continued unchanged in routine practice, never paused on your own initiative |
The table is a guide, not an instruction — the decision is made by your treating practice together with the radiology department.
Digital medication plan
All your preparations in one place — including the over-the-counter ones, which otherwise never come up in radiology. Simply show it during the consent conversation.
Medication reminder
Set a break and store the restart day — so that two planned days without metformin do not turn into two forgotten weeks.
Health history
Kidney values, TSH and earlier contrast agent reactions documented — with dates, so that nothing has to be reconstructed at your next appointment.
Medication plan, lab values and reminders in one place. Free.
Start for free